期刊论文详细信息
Hepatic Oncology | |
HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance | |
Devis Pascut1  Muhammad Yogi Pratama1  Claudio Tiribelli1  | |
[1] 1Fondazione Italiana Fegato – ONLUS, Liver Research Center, AREA Science Park, ss14, Km163.5, Basovizza, 34149 Trieste, Italy; | |
关键词: biomarkers; DAA; direct-acting antiviral; HCC; HCV; | |
DOI : 10.2217/hep-2020-0010 | |
来源: DOAJ |
【 授权许可】
Unknown